Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 29 No. 9, September 2008
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Fimbres, A. M.
Right arrow Articles by Shulman, S. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fimbres, A. M.
Right arrow Articles by Shulman, S. T.
Related Collections
Right arrow Collagen Vascular and Other Multisystem Disorders
Right arrow Cardiovascular Disorders

(Pediatrics in Review. 2008;29:308-316.)
© 2008 American Academy of Pediatrics

Kawasaki Disease


Angela M. Fimbres, MD, MPH*
Stanford T. Shulman, MD{dagger}
 * Fellow, Pediatric Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, Ill
{dagger} Professor of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Ill

The first 300 words of the full text of this article appear below.


   Objectives
 
After completing this article, readers should be able to:

  1. Describe the clinical and laboratory manifestations of Kawasaki disease (KD).
  2. Describe the features of atypical, or incomplete, KD.
  3. Discuss the value of high-dose aspirin and intravenous immune globulin (IVIG) in the treatment of KD and possible therapies for IVIG-refractory KD.
  4. Identify the cardiac complications of KD and the importance of evaluation and follow-up.
  5. Delineate the prognosis and management of KD.


   Introduction
 
Kawasaki disease (KD) is an acute, self-limited vasculitis of unknown cause that has a striking predilection for the coronary arteries of infants and young children. First described in Japan in 1967 by Tomisaku Kawasaki, the disease now is known to occur in the Americas, Europe, and Asia in children of all races. In retrospect, the entity known as infantile polyarteritis nodosa likely is a part of the continuum of KD, and clinically mild KD probably was confused with diseases such as measles or scarlet fever before the advent of vaccines and antibiotics. In fact, old reports on infantile polyarteritis nodosa describe pathologic findings that are identical to those of fatal KD.


   Epidemiology
 
KD is markedly more prevalent in Japan and in children of Japanese ethnicity, having an annual incidence of 150 cases per 100,000 children younger than 5 years of age, about 10 times the rate in the United States. In the United States, the incidence of KD has been estimated recently by using hospital discharge data. An estimated 4,248 hospitalizations associated with KD occurred in the United States in the year 2000, with a median age of 2 years. The incidence of KD was highest among Asians and Pacific Islanders and lowest in white children. Boys outnumbered girls by 3:2, and 76% of children were younger than age 5 years. In-hospital mortality was 0.17%. Virtually all deaths in patients who have . . . [Full Text of this Article]






HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics Pediatrics in Review
Copyright © 2008 by the American Academy of Pediatrics.